The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Hematologic Parameters and Angiographic Progression of Coronary Atherosclerosis
Abstract
Hematologic parameters have prognostic importance in cardiovascular disease. However, the relation between atherosclerosis progression and hematologic parameters is not well defined. A total of 394 patients requiring repeat coronary angiography were included in the study. According to angiography, patients were divided into 2 groups, progressive (n = 196) and nonprogressive (n = 198) diseases. Hematologic parameters including mean platelet volume (MPV) and neutrophil/lymphocyte (N/L) ratio were measured. Glucose, creatinine, and cholesterol were significantly higher in the progressive group. Mean platelet volume count was similar in both groups. The N/L ratio was significantly higher in the progressive group (5.0 ± 5.1 vs 3.2 ± 3; P = .001). In multivariate analysis, the N/L ratio was significantly related with progression (relative risk [RR]: 2.267, 95% CI: 1.068-4.815, P = .03). Progression rate was significantly high in patients with high N/L ratio (39% vs 56%). Our results suggest that the N/L ratio is a predictor of progression of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Zahorec, R. (2001) · Bratislava Medical Journal · doi:10.1007/bf03656390 · Cited by 1,601
Cited by
Neutrophil to lymphocyte ratio and cardiovascular diseases: a review
Bhat, T., Teli, S., Rijal, J., Bhat, H., Raza, M., Khoueiry, G., Meghani, M., Akhtar, M., & Costantino, T. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.159 · Cited by 600
Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update
Afari, M. E., & Bhat, T. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1154788 · Cited by 439
Neutrophil-to-lymphocyte ratio and mortality in the United States general population
Song, M., Graubard, B. I., Rabkin, C. S., & Engels, E. A. (2021) · Scientific Reports · doi:10.1038/s41598-020-79431-7 · Cited by 434
The Relation Between Atherosclerosis and the Neutrophil–Lymphocyte Ratio
Balta, S., Celik, T., Mikhailidis, D. P., Ozturk, C., Demirkol, S., Aparci, M., & Iyisoy, A. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615569568 · Cited by 404
Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases
Mozos, I., Malainer, C., Horbańczuk, J., Gug, C., Stoian, D., Luca, C. T., & Atanasov, A. G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01058 · Cited by 372
Metadata
- Authors
- Kalay, N., Dogdu, O., Koc, F., Yarlıoglues, M., Ardic, I., Akpek, M., Cicek, D., Oguzhan, A., Ergin, A., & Kaya, M. G.
- Venue
- Angiology
- Publisher
- SAGE Publications
- Published
- 2011-07-06
- Volume
- 63
- Issue
- 3
- Pages
- 213-217
- ISSN
- 0003-3197 (ISSN-L)
- 1940-1574
- OpenAlex
- W2162209094
- Cited by
- 163
- References
- 3
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hematologic Parameters and Angiographic Progression of Coronary Atherosclerosis. https://app.cochat.ai/papers/10.1177/0003319711412763
- The paper
- Kalay, N., Dogdu, O., Koc, F., Yarlıoglues, M., Ardic, I., Akpek, M., Cicek, D., Oguzhan, A., Ergin, A., & Kaya, M. G. (2012). Hematologic Parameters and Angiographic Progression of Coronary Atherosclerosis. Angiology. https://doi.org/10.1177/0003319711412763
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.